| Evaluation of the Ocular Safety of Calcium Formate in Normal, Healthy Female Subjects (NCT00204893) | University of Wisconsin, Madison | 2003-07-01 |
| Vaccine Therapy in Treating Patients With Stage IV Cutaneous Melanoma (NCT00074230) | University Hospital Erlangen | 2003-07-01 |
| Safety of an HIV Vaccine (AVX101) in HIV Uninfected Volunteers in the United States and South Africa (NCT00063778) | AlphaVax, Inc. | 2003-07-01 |
| Pharmacokinetics of Tipranavir/Ritonavir and Its Metabolites in Healthy Male Subjects (NCT02253797) | Boehringer Ingelheim | 2003-07-01 |
| Surgery and Intrapleural Docetaxel in Treating Patients With Malignant Pleural Effusion (NCT00114205) | University of Virginia | 2003-07-01 |
| Fed, Bioequivalence Study of Pravastatin Sodium 80 mg Tablets Versus Pravachol® 80 mg Tablets In Subjects (NCT00648544) | Mylan Pharmaceuticals Inc | 2003-07-01 |
| In Vivo Angiostatin Generation Using Tissue Plasminogen Activator and Captopril in Treating Patients With Progressive Metastatic Cancer (NCT00086723) | Northwestern University | 2003-07-01 |
| Feasibility Study of a Percutaneous Mitral Valve Repair System. (NCT00209339) | Abbott Medical Devices | 2003-07-01 |
| Docetaxel and Oxaliplatin in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer (NCT00075543) | GERCOR - Multidisciplinary Oncology Cooperative Group | 2003-07-01 |
| A Study of Plasma Concentrations, Metabolism and Excretion of 14C-paliperidone After a Single Oral Dose (NCT00796029) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2003-07-01 |
| Study Evaluating AMG 706 in Subjects With Advanced Solid Tumors (NCT00093873) | Amgen | 2003-07-01 |
| Treatment With ATRA-IV and Depakote in Patients With Advanced Solid Tumor Malignancies (NCT00195156) | Weill Medical College of Cornell University | 2003-07-01 |
| 15 mg Mirtazapine Orally Disintegrating Tablets, Non-Fasting (NCT00834197) | Teva Pharmaceuticals USA | 2003-07-01 |
| 15 mg Mirtazapine Orally Disintegrating Tablets, Fasting (NCT00835575) | Teva Pharmaceuticals USA | 2003-07-01 |
| Stereotactic Radiotherapy (SRT) Liver (COLD 1) (NCT00152906) | University Health Network, Toronto | 2003-07-01 |
| Safety Study of PI-0824 to Treat Pemphigus Vulgaris (NCT00063752) | Peptimmune | 2003-07-01 |
| Dose Escalation of Bivatuzumab Mertansine in Female Patients With CD44v6 Positive Recurrent or Metastatic Breast Cancer (NCT02254031) | Boehringer Ingelheim | 2003-07-01 |
| Oblimersen, Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma (NCT00070083) | British Columbia Cancer Agency | 2003-07-01 |
| Donor Dendritic Cells And Donor Lymphocytes in Patients With Relapsed Hematologic Malignancies After Allogeneic Transplant (NCT00476177) | Dana-Farber Cancer Institute | 2003-07-01 |
| Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) in Patients With Advanced Cancer (NCT00080418) | INSYS Therapeutics Inc | 2003-07-01 |
| Safety, Tolerance and Pharmacokinetics of Anidulafungin in Immunocompromised Children Ages 2-17 (NCT00056381) | Pfizer | 2003-07-01 |
| Evaluation of Alternative Exercise Treatments on Weight Loss in Overweight Women. (NCT00177632) | University of Pittsburgh | 2003-07-01 |
| Effects of a Dopamine Agonist on Pharmacodynamics of Levodopa in Parkinson's Disease (NCT00666653) | Oregon Health and Science University | 2003-07-01 |
| A Relative Bioavailability Study of Citalopram HBr 10 mg Tablets Under Fasting Conditions (NCT00865943) | Actavis Inc. | 2003-07-01 |
| Suramin and Either Docetaxel or Gemcitabine in Treating Patients With Stage IIIB or Stage IV Platinum-Refractory Non-Small Cell Lung Cancer (NCT00066768) | National Cancer Institute (NCI) | 2003-07-01 |
| Fasting Study of Ondansetron Tablets 24 mg and Zofran® Tablets 24 mg (NCT00649532) | Mylan Pharmaceuticals Inc | 2003-07-01 |
| Imaging Study of the Distribution of IL13-PE38QQR Infused Before and After Surgery in Adult Patients With Recurrent Malignant Glioma (NCT00064779) | INSYS Therapeutics Inc | 2003-07-01 |
| Prevention of High Altitude Pulmonary Edema (NCT00274430) | University of Zurich | 2003-07-01 |
| Anidulafungin in Treating Immunocompromised Children With Neutropenia (NCT00068471) | National Cancer Institute (NCI) | 2003-07-01 |
| Administration of Virus-Specific Cytotoxic T-Lymphocytes (NCT00590083) | Baylor College of Medicine | 2003-07-01 |
| Study of Oral AEE788 in Adults With Advanced Cancer (NCT00118456) | Novartis Pharmaceuticals | 2003-07-01 |
| Combined Approach to Lysis Utilizing Eptifibatide and rt-PA in Acute Ischemic Stroke (CLEAR Stroke) Trial (NCT00250991) | University of Cincinnati | 2003-07-01 |
| Desmopressin Acetate 0.2 mg Tablets, Fasting (NCT00835211) | Teva Pharmaceuticals USA | 2003-07-01 |
| Bioavailability and Effectiveness of Transdermally Administered Morphine (NCT00125684) | Alberta Health services | 2003-07-01 |
| Safety Study of Candidate Malaria Vaccine FMP1/AS02A in Healthy Adults in Bandiagara, Mali (NCT00308061) | U.S. Army Medical Research and Development Command | 2003-07-01 |
| Use of ACA 125 in Patients With Ovarian Cancer: Safety and Immune Response (NCT00103545) | AGO Study Group | 2003-07-01 |
| Vaccine Therapy in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Melanoma (NCT00089219) | University of Virginia | 2003-07-01 |
| Oxaliplatin and Bortezomib in Treating Patients With Advanced Cancer (NCT00066625) | National Cancer Institute (NCI) | 2003-07-01 |
| Bortezomib and Fludarabine With or Without Rituximab in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia (NCT00068315) | National Cancer Institute (NCI) | 2003-07-01 |
| HER-2 Protein Vaccine in Treating Women With Breast Cancer (NCT00068614) | Case Comprehensive Cancer Center | 2003-07-01 |
| Food Study of Ondansetron Tablets 24 mg and Zofran® Tablets 24 mg (NCT00648583) | Mylan Pharmaceuticals Inc | 2003-07-01 |
| Dressing Preparations for Smallpox (NCT00063856) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-07-01 |
| Gefitinib in Combination With Chemoradiation in Resectable Gastric Cancer (NCT00237900) | AstraZeneca | 2003-07-01 |
| A Pilot Study of Lycopene Supplementation in Prostatic Intraepithelial Neoplasia (NCT00178113) | University of Pittsburgh | 2003-07-01 |
| Safety and Efficacy Study of a Hydrogel, Applied Following Removal of Myomas During Gynecologic Surgery, Administered for the Prevention/Reduction of Postoperative Adhesion Formation (NCT00562471) | Angiotech Pharmaceuticals | 2003-07-01 |
| Comparative Bioavailability Study of Clarithromycin 500 mg Tablets in Fasting State (NCT00648960) | Mylan Pharmaceuticals Inc | 2003-07-01 |
| Bioequivalence Study of Clarithromycin 250mg Tablets Under Fasting Conditions (NCT00774189) | Ranbaxy Laboratories Limited | 2003-07-01 |
| Purdue University Parenting Program Attrition (NCT00153439) | Centers for Disease Control and Prevention | 2003-07-01 |
| Combination Chemotherapy, Monoclonal Antibody, and Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma (NCT00068250) | Radiation Therapy Oncology Group | 2003-07-01 |
| Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Post-Transplant Lymphoproliferative Disorder (NCT00064246) | National Cancer Institute (NCI) | 2003-07-01 |
| Pyrimethamine to Treat Autoimmune Lymphoproliferative Syndrome (NCT00065390) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-07-01 |
| Impact of Computerized Reminders on Blood Pressure Documentation and Control (NCT01640704) | Agency for Healthcare Research and Quality (AHRQ) | 2003-07-01 |
| Effects of Oral Glucosamine on Insulin and Blood Vessel Activity in Normal and Obese People (NCT00065377) | National Center for Complementary and Integrative Health (NCCIH) | 2003-07-01 |
| A Dose Finding Phase I Trial of the Combination of Topotecan and PS-341, a Novel Proteasome Inhibitor, in Advanced Malignancies (NCT00068484) | National Cancer Institute (NCI) | 2003-07-01 |
| Effects of Ligands on Human Hair Follicles Grafted Onto SCID Mice (NCT00177099) | Hordinsky, Maria K., MD | 2003-07-01 |
| Study of MDX-010 in Subjects With Unresectable Stage III or Stage IV Malignant Melanoma (NCT00729950) | Bristol-Myers Squibb | 2003-07-01 |
| Induction of Donor Specific Tolerance in Recipients of Cardiac Allografts by Donor Stem Cell Infusion (NCT00497757) | Suzanne T. Ildstad | 2003-07-01 |
| Treatment of Dysphagia Using the Mendelsohn Maneuver (NCT00592761) | University of Arkansas | 2003-07-01 |
| Vaccine Therapy in Treating Patients With Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer (NCT00066729) | Ludwig Institute for Cancer Research | 2003-06-23 |
| Investigating the Safety of srTMS in the Treatment of Parkinson's Disease (NCT00063284) | National Institute of Neurological Disorders and Stroke (NINDS) | 2003-06-18 |
| Study of Irofulven in Combination With Oxaliplatin in Patients With Advanced Solid Tumors (NCT00374660) | Eisai Inc. | 2003-06-01 |
| A Relative Bioavailability Study of Fentanyl 25 μg/h Transdermal System (NCT00864565) | Actavis Inc. | 2003-06-01 |
| Gene Therapy in Preventing Cancer in Patients With Premalignant Carcinoma of the Oral Cavity or Pharynx (NCT00064103) | National Cancer Institute (NCI) | 2003-06-01 |
| Trial to Evaluate the Safety and Immunogenicity of an Anthrax Recombinant Protective Antigen Vaccine (NCT00103467) | VaxGen | 2003-06-01 |
| Flavopiridol and Imatinib Mesylate in Treating Patients With Hematologic Cancer (NCT00064285) | Virginia Commonwealth University | 2003-06-01 |
| Evaluation of Safety of Ciliary Neurotrophic Factor Implants in the Eye (NCT00063765) | National Eye Institute (NEI) | 2003-06-01 |
| Phase I Study of Cisplatin Plus OSI-7904L in Patients With Solid Tumors (NCT00116896) | OSI Pharmaceuticals | 2003-06-01 |
| Bioequivalence Study Comparing 2 Formulations for 4 mg Risperidone Tablet. (NCT00645502) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2003-06-01 |
| Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia (NCT00061945) | National Cancer Institute (NCI) | 2003-06-01 |
| Vaccine Therapy in Treating Patients With Malignant Glioma (NCT00068510) | Jonsson Comprehensive Cancer Center | 2003-06-01 |
| Food Study of Olanzapine Tablets 5 mg and Zyprexa® Tablets 5 mg (NCT00647777) | Mylan Pharmaceuticals Inc | 2003-06-01 |
| Fasting Bioequivalence Study of Pravastatin Sodium 80 mg Tablets Versus Pravachol® 80 mg Tablets In Normal Healthy Subjects (NCT00650221) | Mylan Pharmaceuticals Inc | 2003-06-01 |
| Nutritional Restriction and Activity Thermogenesis (NCT00065338) | Mayo Clinic | 2003-06-01 |
| A Phase I/II Study of Oblimersen Plus Cisplatin and Fluorouracil in Gastric & Esophageal Junction Cancer (NCT00064259) | National Cancer Institute (NCI) | 2003-06-01 |
| An Dose Escalation Study of Treatment With BIBF 1120 in Patients With Advanced Solid Tumours (NCT02182206) | Boehringer Ingelheim | 2003-06-01 |
| A Phase I, Pharmacological, and Biological Study of OSI-774 in Combination With FOLFOX 4 (5-FU, Leucovorin, and Oxaliplatin) and Bevacizumab (Avastin) in Patients With Advanced Colorectal Cancer (NCT00060411) | National Cancer Institute (NCI) | 2003-06-01 |
| Evaluation of Efficiency of Ritalin in Multiple Sclerosis (MS) Patients (NCT00220493) | Sheba Medical Center | 2003-06-01 |
| Tolerability and Safety of Duloxetine BID in Healthy Female Subjects (NCT02232542) | Boehringer Ingelheim | 2003-06-01 |
| Doxorubicin Pharmacokinetic (PK) Study (NCT00124956) | Boston Children's Hospital | 2003-06-01 |
| Hematopoietic Stem Cell Therapy for Patients With Multiple Sclerosis (NCT00278655) | Northwestern University | 2003-06-01 |
| Cyclophosphamide or Denileukin Diftitox Followed By Expanding a Patient's Own T Cells in the Laboratory in Treating Patients With HER-2/Neu Overexpressing Metastatic Breast Cancer, Ovarian Cancer, or Non-Small Cell Lung Cancer Previously Treated With HER-2/Neu Vaccine (NCT00228358) | University of Washington | 2003-06-01 |
| A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers Who Have Received BCG Immunisation 1 Month Previously (NCT00427453) | University of Oxford | 2003-06-01 |
| Influence of Different Degrees of Renal Impairment on the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of BIBT 986 BS in Subjects With Normal Renal Function and Patients With Different Degrees of Renal Impairment (NCT02254070) | Boehringer Ingelheim | 2003-06-01 |
| Combined Bone Marrow and Kidney Transplant for Multiple Myeloma With Kidney Failure (NCT00062621) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-06-01 |
| Intravenous Allopurinol to Improve Heart Function in Individuals With Dilated Cardiomyopathy (NCT00281255) | University of Pennsylvania | 2003-06-01 |
| A Study to Compare the Bioavailability of Two Tramadol Hydrochloride Tablet Products (50 mg and 200 mg, Respectively) at Steady-state Under Fasting Conditions (NCT00834288) | Labopharm Inc. | 2003-06-01 |
| Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor (NCT00049127) | Alliance for Clinical Trials in Oncology | 2003-06-01 |
| Bortezomib and Temozolomide in Treating Patients With Advanced Refractory Solid Tumors or Melanoma (NCT00512798) | Vanderbilt-Ingram Cancer Center | 2003-06-01 |
| Imatinib Mesylate and 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Chronic Myelogenous Leukemia (NCT00066326) | Barbara Ann Karmanos Cancer Institute | 2003-06-01 |
| Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation (NCT00089037) | Fred Hutchinson Cancer Center | 2003-06-01 |
| Bioavailability Investigations of Thyronajod Mite Tablets of Dosage Strengths 50 μg Levothyrox-ine/75 μg Iodine, and 100 μg Levothyroxine/75 μg Iodine vs. a Levothyroxine Drinking-Solution: A Randomised Cross Over Study in Healthy Male Individuals. Currently: 100 μg/ 75 μg Tablets (NCT01465646) | Heidelberg University | 2003-06-01 |
| Study of DN101 and Taxotere in Patients With Advanced Non-Small Cell Lung Cancer (NCT00066885) | Novacea | 2003-06-01 |
| Safety of Combining Modafinil and Nicotine Replacement Therapy in Treating Nicotine Dependent Adolescents (NCT00258479) | Catherine Martin, MD | 2003-06-01 |
| A Worldwide, Phase I, Dose-Escalating Study of a 3-Dose Regimen of the MRKAd5 (Clade B) Vaccine in Healthy Adults (V520-018) (NCT00849732) | Merck Sharp & Dohme LLC | 2003-06-01 |
| Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation (NCT00064311) | National Institutes of Health Clinical Center (CC) | 2003-06-01 |
| A Relative Bioavailability Study of Citalopram 40 mg Tablets Under Fasting Conditions (NCT00865085) | Actavis Inc. | 2003-06-01 |
| The Effects of HIV Protease Inhibitors in Severe Sepsis (NCT00346580) | Mayo Clinic | 2003-06-01 |
| Effects of Single-dose and Steady-state TPV/RTV on the Steady-state Pharmacokinetics of Fluconazole in Healthy Adult Volunteers (NCT02195466) | Boehringer Ingelheim | 2003-06-01 |
| Autologous and Allogeneic Transplant for Relapsed Lymphoma (NCT00802113) | Columbia University | 2003-06-01 |
| Reducing the Risk of Transplant Rejection: Simultaneous Kidney and Bone Marrow Transplant (NCT00063817) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-06-01 |